Cargando…

Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma

BACKGROUND: In this study, we aimed to identify the pathogenesis and prognostic biomarkers of lung adenocarcinoma (LUAD). METHODS: Differentially expressed mRNAs (DEmRNAs) and single nucleotide polymorphism (SNP) mutant genes were screened. In addition, enrichment and protein‐protein interaction (PP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanyun, Zhang, Lin, Chen, Yitong, Li, Man, Ha, Minwen, Li, Songbai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595917/ https://www.ncbi.nlm.nih.gov/pubmed/32672359 http://dx.doi.org/10.1002/jcla.23450

Ejemplares similares

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma
por: Liu, Zhonghui, et al.
Publicado: (2021)

Identification of urine biomarkers associated with lung adenocarcinoma
por: Wang, Weiwei, et al.
Publicado: (2017)

Identification of lysosomal genes associated with prognosis in lung adenocarcinoma
por: Li, Houqiang, et al.
Publicado: (2023)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
por: Fan, Zhengyang, et al.
Publicado: (2023)

Tubulin Alpha-1b as a Potential Biomarker for Lung Adenocarcinoma Diagnosis and Prognosis
por: Pang, Xue-Li, et al.
Publicado: (2023)

Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis
por: Li, Jinghang, et al.
Publicado: (2020)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

Identification of specific biomarkers for gastric adenocarcinoma by ITRAQ proteomic approach
por: Wang, Xiaoxiao, et al.
Publicado: (2016)

Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021)

m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer
por: Wang, Yanyun, et al.
Publicado: (2021)

Identification of potential biomarkers for lung adenocarcinoma
por: Sayeeram, Deepak, et al.
Publicado: (2020)

Association of thymidylate synthase gene 3'-untranslated region polymorphism with sensitivity of non-small cell lung cancer to pemetrexed treatment: TS gene polymorphism and pemetrexed sensitivity in NSCLC
por: Wang, Xia, et al.
Publicado: (2013)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2020)

Identification of a long non-coding RNA signature for predicting prognosis and biomarkers in lung adenocarcinoma
por: Yu, Xiaolin, et al.
Publicado: (2020)

Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis
por: Chen, Hongyu, et al.
Publicado: (2022)

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
por: Yao, Yan, et al.
Publicado: (2021)

Identification and Validation of Two Lung Adenocarcinoma-Development Characteristic Gene Sets for Diagnosing Lung Adenocarcinoma and Predicting Prognosis
por: Liu, Cheng, et al.
Publicado: (2020)

Identification of hallmarks of lung adenocarcinoma prognosis using whole genome sequencing
por: Liu, Li, et al.
Publicado: (2015)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Bioinformatics Identification of Key Genes for the Development and Prognosis of Lung Adenocarcinoma
por: Luo, Xuan, et al.
Publicado: (2022)

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer
por: Liu, Xingyuan, et al.
Publicado: (2019)

Identification of Inflammatory Response-Related Gene Signature Associated With Immune Status and Prognosis of Lung Adenocarcinoma
por: Zou, Weijie, et al.
Publicado: (2021)

HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma
por: Zou, Xin, et al.
Publicado: (2022)

High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
por: Qi, Shi-ang, et al.
Publicado: (2021)

Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis
por: Li, Jianliang, et al.
Publicado: (2019)

mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers
por: Zhang, Yitong, et al.
Publicado: (2020)

Effects of autophagy-associated genes on the prognosis for lung adenocarcinoma
por: Chen, Chongxiang, et al.
Publicado: (2020)

Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma
por: Wang, XiaoFang, et al.
Publicado: (2023)

Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022)

Identification of TRIM56 as a Potential Biomarker for Lung Adenocarcinoma
por: Lu, Kun, et al.
Publicado: (2021)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy
por: Song, Yongan, et al.
Publicado: (2023)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
por: Song, Qian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fevfqi4jafouo3t57g31du3c8n